AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 26-50/55
Infections osteoarthritis caused by Pseudallescheria boydii and a secondarily dissemination in an immunocompromised patient.
Authors: Miegeville, M le Gouill, S Moreau, PH Morineau, N Harousseau, JL
Citation: M. Miegeville et al., Infections osteoarthritis caused by Pseudallescheria boydii and a secondarily dissemination in an immunocompromised patient., J MYCOL MED, 9(1), 1999, pp. 57-60
Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells
Authors: Pellat-Deceunynck, C Jego, G Harousseau, JL Vie, H Bataille, R
Citation: C. Pellat-deceunynck et al., Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells, CLIN CANC R, 5(3), 1999, pp. 705-709
Myeloma cells release soluble interleukin-6R alpha in relation to disease progression by two distinct mechanisms: Alternative splicing and proteolytic cleavage
Authors: Thabard, W Barille, S Collette, M Harousseau, JL Rapp, MJ Bataille, R Amiot, M
Citation: W. Thabard et al., Myeloma cells release soluble interleukin-6R alpha in relation to disease progression by two distinct mechanisms: Alternative splicing and proteolytic cleavage, CLIN CANC R, 5(10), 1999, pp. 2693-2697
Amplification of the IIq23 region in acute myeloid leukemia
Authors: Avet-Loiseau, H Godon, C Li, JY Daviet, A Mellerin, MP Talmant, P Harousseau, JL Bataille, R
Citation: H. Avet-loiseau et al., Amplification of the IIq23 region in acute myeloid leukemia, GENE CHROM, 26(2), 1999, pp. 166-170
Autologous peripheral blood progenitor cell transplantation for multiple myeloma
Authors: Attal, M Harousseau, JL
Citation: M. Attal et Jl. Harousseau, Autologous peripheral blood progenitor cell transplantation for multiple myeloma, BAIL CLIN H, 12(1-2), 1999, pp. 171-191
Lack of efficacy of clarithromycin in advanced multiple myeloma
Authors: Moreau, P Huynh, A Facon, T Bouilly, I Sotto, JJ Legros, L Milpied, N Attal, M Bataille, R Harousseau, JL
Citation: P. Moreau et al., Lack of efficacy of clarithromycin in advanced multiple myeloma, LEUKEMIA, 13(3), 1999, pp. 490-491
Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy
Authors: Puthier, D Pellat-Deceunynck, C Barille, S Robillard, N Rapp, MJ Juge-Morineau, N Harousseau, JL Bataille, R Amiot, M
Citation: D. Puthier et al., Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancy, LEUKEMIA, 13(2), 1999, pp. 289-294
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients
Authors: Bouabdallah, R Lefrere, F Rose, C Chaibi, P Harousseau, JL Vernant, JP Castaigne, S Bauduer, F Zini, JM Coso, D Varet, B Robert, J Fenaux, P
Citation: R. Bouabdallah et al., A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients, LEUKEMIA, 13(10), 1999, pp. 1491-1496
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment
Authors: Derenne, S Amiot, M Barille, S Collette, M Robillard, N Berthaud, P Harousseau, JL Bataille, R
Citation: S. Derenne et al., Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment, J BONE MIN, 14(12), 1999, pp. 2048-2056
Low-grade stage III-IV follicular lymphoma: Multivariate analysis of prognostic factors in 484 patients - A study of the Groupe d'Etude des Lymphomesde l'Adulte
Authors: Decaudin, D Lepage, E Brousse, N Brice, P Harousseau, JL Belhadj, K Tilly, H Michaux, L Cheze, S Coiffier, B Solal-Celigny, P
Citation: D. Decaudin et al., Low-grade stage III-IV follicular lymphoma: Multivariate analysis of prognostic factors in 484 patients - A study of the Groupe d'Etude des Lymphomesde l'Adulte, J CL ONCOL, 17(8), 1999, pp. 2499-2505
Optimizing peripheral blood progenitor cell autologous transplantation in multiple myeloma
Authors: Harousseau, JL
Citation: Jl. Harousseau, Optimizing peripheral blood progenitor cell autologous transplantation in multiple myeloma, HAEMATOLOG, 84(6), 1999, pp. 548-553
Intensive therapy in multiple myeloma
Authors: Harousseau, JL
Citation: Jl. Harousseau, Intensive therapy in multiple myeloma, PATH BIOL, 47(2), 1999, pp. 203-209
Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation
Authors: Milpied, N Coste-Burel, M Accard, F Moreau, A Moreau, P Garand, R Harousseau, JL
Citation: N. Milpied et al., Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation, BONE MAR TR, 23(6), 1999, pp. 629-630
Melphalan 220 mg/m(2) followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma
Authors: Moreau, P Milpied, N Mahe, B Juge-Morineau, N Rapp, MJ Bataille, R Harousseau, JL
Citation: P. Moreau et al., Melphalan 220 mg/m(2) followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma, BONE MAR TR, 23(10), 1999, pp. 1003-1006
Pseudallescheria boydii arthritis in a patient with acute lymphoblastic leukemia: A case report.
Authors: Le Gouill, S Morineau, N Miegeville, M Milpied, N Harousseau, JL Moreau, P
Citation: S. Le Gouill et al., Pseudallescheria boydii arthritis in a patient with acute lymphoblastic leukemia: A case report., REV MED IN, 20(5), 1999, pp. 434-438
Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation
Authors: Barille, S Bataille, R Rapp, MJ Harousseau, JL Amiot, M
Citation: S. Barille et al., Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation, J IMMUNOL, 163(10), 1999, pp. 5723-5728
14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesisof multiple myeloma
Authors: Avet-Loiseau, H Facon, T Daviet, A Godon, C Rapp, MJ Harousseau, JL Grosbois, B Bataille, R
Citation: H. Avet-loiseau et al., 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesisof multiple myeloma, CANCER RES, 59(18), 1999, pp. 4546-4550
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia
Authors: Ifrah, N Witz, F Jouet, JP Francois, S Lamy, T Linassier, C Pignon, B Berthou, C Guyotat, D Cahn, JY Harousseau, JL
Citation: N. Ifrah et al., Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia, CANCER, 86(8), 1999, pp. 1496-1505
High-dose melphalan in patients with multiple myeloma
Authors: Moreau, P Le Bonniec, M Harousseau, JL
Citation: P. Moreau et al., High-dose melphalan in patients with multiple myeloma, B CANCER, 86(3), 1999, pp. 283-288
Chemoinduced leukemias
Authors: Harousseau, JL
Citation: Jl. Harousseau, Chemoinduced leukemias, B CANCER, 86(11), 1999, pp. 929-937
Mcl-1 and Bcl-x(L) are co-regulated by IL-6 in human myeloma cells
Authors: Puthier, D Derenne, S Barille, S Moreau, P Harousseau, JL Bataille, R Amiot, M
Citation: D. Puthier et al., Mcl-1 and Bcl-x(L) are co-regulated by IL-6 in human myeloma cells, BR J HAEM, 107(2), 1999, pp. 392-395
P53 deletion is not a frequent event in multiple myeloma
Authors: Avet-Loiseau, H Li, JY Godon, C Morineau, N Daviet, A Harousseau, JL Facon, T Bataille, R
Citation: H. Avet-loiseau et al., P53 deletion is not a frequent event in multiple myeloma, BR J HAEM, 106(3), 1999, pp. 717-719
CD130 rather than CD126 expression is associated with disease activity in multiple myeloma
Authors: Barille, S Thabard, W Robillard, N Moreau, P Pineau, D Harousseau, JL Bataille, R Amiot, M
Citation: S. Barille et al., CD130 rather than CD126 expression is associated with disease activity in multiple myeloma, BR J HAEM, 106(2), 1999, pp. 532-535
Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
Authors: Avet-Loiseau, H Li, JY Morineau, N Facon, T Brigaudeau, C Harousseau, JL Grosbois, B Bataille, R
Citation: H. Avet-loiseau et al., Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma, BLOOD, 94(8), 1999, pp. 2583-2589
Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirementsin multiple myeloma patients: A randomized, controlled trial
Authors: Facon, T Harousseau, JL Maloisel, F Attal, M Odriozola, J Alegre, A Schroyens, W Hulin, C Schots, R Marin, P Guilhot, F Granena, A De Waele, M Pigneux, A Meresse, V Clark, P Reiffers, J
Citation: T. Facon et al., Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirementsin multiple myeloma patients: A randomized, controlled trial, BLOOD, 94(4), 1999, pp. 1218-1225
Risultati: 1-25 | 26-50 | 51-55